{
  "trial_id": "NCT03837444",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Biomarker measurements",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age between 18 and 90 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Child-Pugh B or Child-Pugh C cirrhosis diagnosed on the basis of one or several of the following elements : Liver Biopsy, Liver stiffness>15kPa measured by Fibroscan, Combination of clinical, laboratory and imaging criteria characteristic of cirrhosis (association of signs of portal hypertension, liver failure and abnormal liver morphology in a patient with at least one cause of cirrhosis)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Measurement of the primary endpoint will be performed according to the recommendations specific for survival analysis in patients with cirrhosis, using a survival analysis that considers liver transplantation as a competitive risk.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Acute renal failure (increase in serum creatinin level by more than 1.5 times the baseline value or by more than 26 \u03bcmol/l from the baseline value) within 15 days",
      "label": "does_not_trigger",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has cirrhosis, grade II esophageal varices, and recent admission for UGIB. He is being treated with lactulose and has a presumptive diagnosis of hepatic encephalopathy.",
  "_meta": {
    "topic_id": "7",
    "trial_id": "NCT03837444",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}